Domains selection for patient-reported outcomes: Current activities and options for future methods

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1702-1710

  Tugwell, Peter S ^a,b,c   Petersson, Ingemar F ^d   Boers, Maarten ^e   Gossec, Laure ^f   Kirwan, John R ^g   Rader, Tamara ^a   Sanderson, Tessa C ^h   Van De Laar, Mart A ⁱ   Ueffing, Erin ^a   Witter, James P ^j  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d LUND UNIVERSITY   (Sweden)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

ⁱ UNIVERSITY OF TWENTE   (Netherlands)

^j NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

more..

Author keywords

Outcome measures; Patient reported outcomes; Rheumatoid arthritis

Indexed keywords

ANALYTIC METHOD; ANALYTICAL PARAMETERS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONCEPTUAL FRAMEWORK; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATIGUE; HEALTH CARE CONCEPTS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HUMAN; OUTCOME ASSESSMENT; OUTCOME MEASURES IN RHEUMATOLOGY CLINICAL TRIALS; PATIENT ATTITUDE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SELF REPORT; SOCIAL ENVIRONMENT; TREATMENT PLANNING;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DISABILITY EVALUATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79961110322     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110389     Document Type: Conference Paper

References (35)

1. Fries JF. The chronic disease data bank model: a conceptual framework for the computer-based medical record. Comput Biomed Res 1992;25:586-601.
2. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. [Internet. Accessed April 7, 2011.] Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulat oryInformation/Guidances/UCM193282.pdf
3. Boonen A, Stucki G, Maksymowych W, Rat AC, Escorpizo R, Boers M. The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challenges. J Rheumatol 2009;36:2057-60.
4. World Health Organization. Towards a common language for functioning, disability and health. ICF. Geneva: World Health Organization; 2002. [Internet. Accessed April 7, 2011.] Available from: http://www.who.int/classifications/icf/ training/icf beginnersguide.pdf
5. Weigl M, Cieza A, Cantista P, Reinhardt JD, Stucki G. Determinants of disability in chronic musculoskeletal health conditions: a literature review. Eur J Phys Rehabil Med 2008;44:67-79.
6. Swinkels RAHM. Measurement instruments for patients with rheumatic disorders: a clinimetric appraisal. Amsterdam: Vrije Universiteit; 2005.
7. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45 Suppl 1:S3-S11.
8. PROMIS domains. Domain hierarchy framework. PROMIS Health Organization and the PROMIS Cooperative Group; 2008. [Internet. Accessed May 4 2011] Available from: http://www.nihpromis.org/Documents/PROMIS-Full-Framework.pdf
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
10. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5.
11. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. An additional core set generated by people with rheumatoid arthritis: RA Patient Priorities for Pharmacological Interventions (RAPP-PI) [abstract]. Arthritis Rheum 2009;60 Suppl:1205.
12. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res 2010;62:647-56.
13. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-80.
14. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res 2010;62:640-6.
15. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
16. Lansbury J. Numerical method of evaluating the status of rheumatoid arthritis. Ann Rheum Dis 1958;17:101-7.
17. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40. (Pubitemid 23175613)
18. Wells G, Anderson J, Beaton D, Bellamy N, Boers M, Bombardier C, et al. Minimal clinically important difference module: summary, recommendations, and research agenda. J Rheumatol 2001;28:452-4. (Pubitemid 32165168)
19. Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum 2007;57:429-39. (Pubitemid 46682530)
20. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: the patient's perspective. J Rheumatol 2003;30:880-3. (Pubitemid 36402793)
21. Ahlmen M, Nordenskiold U, Archenholtz B, Thyberg I, Ronnqvist R, Linden L, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology 2005;44:105-10. (Pubitemid 40124341)
22. Hewlett S, Carr M, Ryan S, Kirwan J, Richards P, Carr A, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005;3:131-42.
23. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17. (Pubitemid 26258765)
24. Milton HV, Hewlett S, Kirwan JR. Fatigue in rheumatoid arthritis [abstract]. Rheumatology 2002;41 Suppl 2:73.
25. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005;53:697-702. (Pubitemid 41463834)
26. Repping-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T. Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008;45:995-1002.
27. Tack BB. Fatigue in rheumatoid arthritis. Conditions, strategies, and consequences. Arthritis Care Res 1990;3:65-70. (Pubitemid 20360402)
28. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7. (Pubitemid 46774870)
29. Nikolaus S, Bode C, Taal E, van de Laar MAFJ. New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study. Ann Rheum Dis 2010;69:895-7.
30. The Cochrane Collaboration. Working together to provide the best evidence for health care. 2010. [Internet. Accessed April 7, 2011.] Available from: http://www.cochrane.org/
31. Maxwell L, Santesso N, Tugwell PS, Wells GA, Judd M, Buchbinder R. Method guidelines for Cochrane Musculoskeletal Group systematic reviews. J Rheumatol 2006;33:2304-11. (Pubitemid 44749793)
32. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12-A13.
33. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ 2006;333:804-6. (Pubitemid 44583363)
34. Sanderson T, Hewlett S, Flurey C, Dures E, Richards P, Kirwan J. The impact triad (incorporating severity, importance and self-management) as a method of enhancing the measurement of the personal life impact of rheumatic diseases. J Rheumatol 2011;38:191-4.
35. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.